Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.
Catching pancreatic cancer early is among the most difficult challenges faced by medical providers, and that delay often ends in death. The NIH-supported researchers’ discovery of a new blood test, ...